The Corporate Reputation of Pharma - The Perspective in 2015 of 257 Neurological Patient Groups

  • ID: 3942636
  • Report
  • 65 pages
  • PatientView
1 of 4

FEATURED COMPANIES

  • AbbVie
  • AstraZeneca
  • Bristol-Myers Squibb
  • Ipsen
  • Merck KGaA
  • Roche
  • MORE

This report is based on the findings of a November 2015-January 2016 survey exploring the views of 257 neurological patient groups worldwide. The report provides feedback on the corporate reputation of the pharma industry during 2015, from the perspective of these patient groups, as well as the performance of 29 pharma companies for six key indicators that influence corporate reputation. Results are compared with those of the previous year.

The report also offers, as a case study survey responses from one Israeli company, Teva. Teva explains what they are doing on the subject of global patient centricity, and comment about their relationships with patient groups.

“I think that fair pricing is very important, combined with high quality. In other words, a balance between quality and price.”  

—National Belgium-based patient group specialising in a neurological condition

Profiles Of the 29 Companies, According To the Neurological Patient Groups Familiar with These Companies, or Have Worked With Them

Each profile contains

Company Background Information

  •     Annual revenue (latest-available year), comprising amount in currency, as quoted by the profiled company itself. Increase in revenue over the previous year or decrease in revenue.
  •     The profiled company’s main treatment subject areas (and areas of R&D).
  •     A mission statement from the profiled company.

How the Company Has Performed At Six Indicators of Corporate Reputation

  •  The profiled company’s performance at the six indicators of corporate reputation in 2015, according to the neurological patient groups familiar with the company.
  •  The profiled company’s performance at the six indicators of corporate reputation, according to the neurological patient groups that have worked with the company.
  •  How the profiled company performed among neurological patient groups for different countries/regions, compared with the company’s global averages for neurological patient groups in 2015.

How the Company Ranks For Corporate Reputation Compared With Other Companies

  •  The profiled company’s rankings among neurological patient groups in 2015 for the six indicators of corporate reputation, compared with 28 other companies.
  •  The profiled company’s rankings worldwide in 2015 for the six indicators of corporate reputation, compared with 47 other companies.

Profile of The Patient Groups Familiar With The Company

  •  Other companies that partner with a significant number of the profiled company’s partner patient groups.
  •  The countries of the patient groups familiar with the profiled company.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AbbVie
  • AstraZeneca
  • Bristol-Myers Squibb
  • Ipsen
  • Merck KGaA
  • Roche
  • MORE

ABOUT THIS REPORT 

WHAT DID NEUROLOGICAL PATIENT GROUPS SAY ABOUT PHARMA IN 2015?

  • Summary of the industry-wide findings from among neurological patient groups

A FEW COMMENTS ON THE NEUROLOGICAL CORPORATE RANKINGS 

WHAT CAN PHARMA COMPANIES DO TO IMPROVE THEIR CORPORATE REPUTATION?

COMMENTS FROM NEUROLOGICAL PATIENT GROUPS, 2015 

CASE STUDY: PATIENT-GROUP RELATIONS AND PATIENT CENTRICITY AT...

  • Teva

METHODOLOGY OF THE PATIENT-GROUP SURVEY 

QUESTIONNAIRE FOR PHARMA COMPANIES 2015 

APPENDIX 1: Data on how neurological patient groups see the pharmaceutical industry in 2015, and in 2014
APPENDIX 2: Rankings of the 29 pharma companies for each of the 6 indicators of corporate reputation, as perceived by neurological patient groups in 2015, compared with 20
APPENDIX 3: Profiles of the 29 companies
APPENDIX 4: Profiles of the 257 respondent neurological patient groups

LIST OF TABLES AND CHARTS—BASED ON THE VIEWS OF NEUROLOGICAL PATIENT GROUPS, 2015
Percentage of neurological patient groups claiming familiarity with the company 
Percentage of neurological patient groups claiming familiarity, and which also worked with the company 
The percentage of patient groups that stated pharma was in 2015 "Excellent" or "Good" at BEING PHILANTHROPIC 
% of patient groups (by specialty) stating that pharma was “Excellent” or “Good” at fair pricing in 2015 
Rising stars, neurological, 2015 (companies rising up the ranks, 2015 v 2014, or leading the ranks in 2015)  
If a pharma company wishes to improve its corporate reputation with patients and patient groups, which single strategy from the list below do you think would be MOST IMPORTANT for the company to follow? Please select only ONE option
How do you think your organisation’s members (or the people you represent) would rate the corporate reputation of the following healthcare sectors in 2015?
How do you think your organisation’s members (or the people you represent) would rate the corporate reputation of the pharma industry in 2015?
What do you think has happened to the corporate reputation of the pharma industry over the past five years? 
How good or bad do you think the pharma industry is in 2015 at carrying out the following activities (all of which influence their corporate standing with patients and patient groups)?
How good or bad do you think the pharma industry is in 2015 at carrying out the following activities (all of which influence their corporate standing with patients and patient groups)? (Year-on-year comparators: neurological, 2015; neurological, 2014; and global, 2015)
Companies with the most effective patient-centred strategy (rankings of 29 companies, 2015; rankings of companies, 2014)
Companies providing the best high-quality patient information (rankings of 29 companies, 2015; rankings of companies, 2014)
Companies with the best record on patient safety (rankings of 29 companies, 2015; rankings of 18 companies, 2014)
Companies with the most-useful high-quality products (rankings of 29 companies, 2015; rankings of 18 companies, 2014)
Companies with the best record of transparency (rankings of 29 companies, 2015; rankings of 18 companies, 2014)
Companies with the best record on integrity (rankings of 29 companies, 2015; rankings of 18 companies, 2014)  
Rankings of the 29 pharmaceutical companies in 2015, ALPHABETIC ORDER
Rankings of the 29 pharmaceutical companies in 2015, HIGHEST TO LOWEST

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • AbbVie
  • Actavis
  • Allergan
  • Amgen
  • AstraZeneca
  • Bayer
  • Biogen Idec
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Eisai
  • Grünenthal
  • GSK
  • Ipsen
  • Janssen
  • Lundbeck
  • Merck & Co
  • Merck KGaA
  • Mylan
  • Novartis
  • Pfizer
  • Roche
  • Sandoz
  • Sanofi
  • Servier
  • Shire
  • Takeda
  • Teva
  • UCB
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll